Comprehensive risk assessment for early neurologic complications after liver transplantation

Table 1 Baseline characteristics of the 288 consecutive liver transplantation patients

Recipient variables
Demographics
Age (yr)	52.3 ± 9.81
Gender (M/F)	213/75
BMI (kg/m2)	24.4 ± 3.72
Primary diagnosis, n (%)
Hepatitis B	175 (60.8)
Hepatitis C	73 (25.3)
Alcoholic liver disease	77 (26.7)
HCC	138 (47.9)
Severity of liver disease
Child-Pugh score	10.0 ± 2.49
MELD score	15.0 ± 9.01
Complication, n (%)
Hepatic encephalopathy	132 (45.8)
Ascites	189 (65.6)
Variceal bleeding	114 (39.6)
Comorbidities, n (%)
Diabetes mellitus	103 (35.7)
Hypertension	52 (18.1)
Uremia	14 (4.9)
Mental disorders	99 (34.4)
Blood test before transplant
Glucose (mg/dL)	129 ± 76.07
Albumin (g/dL)	3.08 ± 0.66
Creatinine (mg/dL)	1.22 ± 1.53
INR	1.62 ± 0.99
T. bilirubin (mg/dL)	7.78 ± 11.19
Platelet (× 103/μL)	85.4 ± 53.85
Ammonia (μg/dL)	138.0 ± 97.05
Perioperative variables
Blood loss (mL)	2896 ± 3409
Operation time (min)	575 ± 122.7
Splenectomy, n (%)	87 (30.2)
Complex vascularity, n (%)	75 (26.0)
Postoperative variables
Tacrolimus dose (mg/d)	3.4 ± 1.67
Basiliximab, n (%)	51 (18)
Serum level - Day 7
Tacrolimus level (ng/mL)	7.4 ± 6.24
Ammonia (μg/dL)	69.6 ± 130.8
Sodium (mmol/L)	136 ± 4.92
Magnesium (mEq/L)	1.73 ± 0.34
Donor variables
Age (yr)	33 ± 11.21
Male gender, n (%)	171 (59.4)
Graft weight (g)	872 ± 357.88
Graft type	95/47/142/4
(whole/left/right/S67), n (%)	(33.0/16.3/49.3/1.4)
Donor-recipient matching
GRWR (%)	1.34 ± 0.57
ABO incompatible, n (%)	9 (3.1)
Gender match (MM/MF/FM/FF), n (%)	128/44/86/30 (44.4/15.3/29.9/10.4)
Surgeon variables
Surgeon A/B/C, n (%)	234/51/3 (81/18/1)
Sequence of transplantation	1-288

BMI: Body mass index; HCC: Hepatocellular carcinoma; MELD: Model for end-stage liver disease; GRWR: Graft-recipient weight ratio.